Literature DB >> 11708809

Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas.

T Tsuji1, I Nozaki, M Miyazaki, M Sakaguchi, H Pu, Y Hamazaki, O Iijima, M Namba.   

Abstract

We recently reported the cloning of the REIC/Dkk-3 gene, whose expression was shown to be down-regulated in many human immortalized and tumor-derived cell lines [T. Tsuji et al. (2000) Biochem. Biophys. Res. Commun. 268, 20-24]. In the present study, we demonstrated that expression of the exogenous REIC/Dkk-3 gene in tumor cells inhibited cell growth. Furthermore, the level of REIC/Dkk-3 mRNA in normal human cells was lowest in the late G(1) phase during the cell cycle. Then we found that the expression of REIC/Dkk-3 was significantly down-regulated in surgically resected non-small-cell lung carcinomas. We determined the REIC/Dkk-3 locus on chromosome 11p15, where loss of heterozygosity has frequently been observed in human tumors. These findings indicate that REIC/Dkk-3 may function as a tumor suppressor. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708809     DOI: 10.1006/bbrc.2001.5972

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancer.

Authors:  An You; Emmanouil Fokas; Lin-Fang Wang; Haitao He; Beate Kleb; Dieter Niederacher; Rita Engenhart-Cabillic; Han-Xiang An
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-09       Impact factor: 4.553

2.  Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.

Authors:  Thanh H Dellinger; Kestutis Planutis; Danielle D Jandial; Ramez N Eskander; Micaela E Martinez; Xiaolin Zi; Bradley J Monk; Randall F Holcombe
Journal:  Gynecol Oncol       Date:  2012-04-30       Impact factor: 5.482

3.  Tumor-induced osteomalacia.

Authors:  Emily G Farrow; Kenneth E White
Journal:  Expert Rev Endocrinol Metab       Date:  2009-09-01

4.  Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro.

Authors:  Yu-Mei Gu; Yi-Hui Ma; Wu-Gan Zhao; Jie Chen
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

5.  Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Authors:  Ramez N Eskander; Shamshad Ali; Thanh Dellinger; Heather A Lankes; Leslie M Randall; Nilsa C Ramirez; Bradley J Monk; Joan L Walker; Eric Eisenhauer; Bang H Hoang
Journal:  Int J Gynecol Cancer       Date:  2016-01       Impact factor: 3.437

6.  Zebrafish Dkk3a protein regulates the activity of myf5 promoter through interaction with membrane receptor integrin α6b.

Authors:  Chuan-Yang Fu; Ying-Fang Su; Ming-Hsuan Lee; Geen-Dong Chang; Huai-Jen Tsai
Journal:  J Biol Chem       Date:  2012-09-28       Impact factor: 5.157

7.  Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3'-side of the transgene.

Authors:  Endy Widya Putranto; Rie Kinoshita; Masami Watanabe; Takuya Sadahira; Hitoshi Murata; Ken-Ichi Yamamoto; Junichiro Futami; Ken Kataoka; Yusuke Inoue; I Made Winarsa Ruma; I Wayan Sumardika; Chen Youyi; Miyoko Kubo; Yoshihiko Sakaguchi; Kenji Saito; Yasutomo Nasu; Hiromi Kumon; Nam-Ho Huh; Masakiyo Sakaguchi
Journal:  Oncol Lett       Date:  2017-05-17       Impact factor: 2.967

8.  Generation and characterization of dickkopf3 mutant mice.

Authors:  Ivan del Barco Barrantes; Ana Montero-Pedrazuela; Ana Guadaño-Ferraz; Maria-Jesus Obregon; Raquel Martinez de Mena; Valérie Gailus-Durner; Helmut Fuchs; Tobias J Franz; Svetoslav Kalaydjiev; Martina Klempt; Sabine Hölter; Birgit Rathkolb; Claudia Reinhard; Gabriella Morreale de Escobar; Juan Bernal; Dirk H Busch; Wolfgang Wurst; Eckhard Wolf; Holger Schulz; Svetlana Shtrom; Erich Greiner; Martin Hrabé de Angelis; Heiner Westphal; Christof Niehrs
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

9.  Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients.

Authors:  F Leung; A Dimitromanolakis; H Kobayashi; E P Diamandis; V Kulasingam
Journal:  Clin Biochem       Date:  2013-03-23       Impact factor: 3.281

10.  Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics.

Authors:  Anna Prudova; Ulrich auf dem Keller; Georgina S Butler; Christopher M Overall
Journal:  Mol Cell Proteomics       Date:  2010-03-20       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.